The Impact of Myasthenia Gravis in the Real World

Vitaccess

Status: Completed

Conditions: Myasthenia Gravis

Study type: Observational

Funder types: Industry

Identifiers

NCT04176211

5105-08-2019

Details and patient eligibility

About

An international, non-interventional, prospective, community recruited, longitudinal, lifestyle study which aims to collect Real-World Evidence (RWE) from people living with myasthenia gravis (MG) in order to map the disease's natural history, its burden on patients and their families, its treatment, as well as its medical, social and pharmacoeconomic impact.

Full description

Data was collected from people with MG using the MyRealWorld™ RWE platform , developed by the healthcare digital research company, Vitaccess. Participants downloaded a 'bring your own device' (BYOD) study app, MyRealWorld™ MG, onto their smartphones, which they used to enter data and complete surveys about their MG.

Enrollment: 2,847 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults (aged 18 years and over) with any stage and any subtype of myasthenia gravis disease
• Resident in Belgium, Canada, France, Germany, Italy, Japan, Spain, the UK, the USA, or Denmark

Exclusion criteria

• No specific exclusion criteria